Attorney Advertising  ·  The Alvarez Law Firm  ·  Coral Gables, FL

This case is actively accepting new filers. Check if you qualify — free, 2 minutes.
LAWSUIT
Loop
See If You Qualify
Court Update Drug Safety Weight Loss Drugs

Weight Loss Shot Lawsuits Just Hit a Major Court Moment — Here’s What It Means for You

On April 28, 2026, a key deadline passed in federal court for the Ozempic, Wegovy, and Mounjaro injury cases. Over 3,500 people who say these weight loss shots caused serious harm are now in a federal case that is picking up speed. Here’s what happened and what it means if you were hurt.

By Lawsuit Loop Staff · Published Apr 29, 2026 · 7 min read · Case is open
Stock image — not an actual client or event

The short version: The federal case against the makers of Ozempic, Wegovy, Mounjaro, and similar weight loss shots just cleared a key court step. Over 3,500 people who say these drugs caused serious stomach problems, gallbladder damage, or vision loss are part of a federal case (MDL 3094) in Philadelphia. If you were hurt by one of these drugs, the window to get into the case is open but will not stay open forever.

This article explains what happened on April 28, what these cases are about, and whether your situation might fit. If you want to skip straight to the form, it’s at the bottom of this page.

Free Case Check · 2 Minutes
Took a weight loss shot and had serious side effects? Check if your situation may qualify — no fee unless you win.

What Happened on April 28

April 28, 2026 was the deadline for both sides in the federal Ozempic/GLP-1 case to submit what are called “Daubert motions.” These are formal filings where each side argues about what kinds of scientific evidence and expert witnesses should be allowed at trial.

In plain terms: this is the step just before a case can go to a jury. When a big federal case with thousands of people reaches this stage, it typically means one of two things is coming — a trial that sets a precedent for how much these cases are worth, or a settlement negotiation that gets serious fast.

Either way, cases at this stage move forward. And the longer someone waits to join, the more complicated it gets to get in on the same terms as everyone already in the case.

What Are These Drugs, and What Are People Saying They Caused?

Ozempic, Wegovy, Mounjaro, Zepbound, Saxenda, and similar shots belong to a drug family called GLP-1 receptor agonists. They were originally developed for type 2 diabetes and were later approved and heavily marketed for weight loss. Millions of Americans now take them.

The people in the federal case say these drugs caused serious health problems that the drug companies did not adequately warn about. The most common injuries being reported:

  • Stomach paralysis (gastroparesis): The stomach stops moving food into the intestines the way it should. This causes severe nausea, vomiting, and pain that can last months or become permanent. About 3 out of 4 cases in the federal case involve this injury.
  • Gallbladder disease and removal: Rapid weight loss from GLP-1 drugs is associated with gallstone formation. Many people have had to have their gallbladder removed.
  • Vision loss (NAION): A smaller group has reported a specific type of vision loss called non-arteritic anterior ischemic optic neuropathy — a sudden, painless loss of vision in one eye. These cases are being handled in a separate track.

Which Drugs Are Part of This Case?

The federal case covers several GLP-1 drugs, including:

  • Ozempic (semaglutide) — Novo Nordisk
  • Wegovy (semaglutide) — Novo Nordisk
  • Mounjaro (tirzepatide) — Eli Lilly
  • Zepbound (tirzepatide) — Eli Lilly
  • Rybelsus (semaglutide, oral) — Novo Nordisk
  • Saxenda (liraglutide) — Novo Nordisk

If you took a different GLP-1 weight loss drug and had serious side effects, it’s still worth submitting your information. The scope of the case may expand as more is known.

Who May Qualify

You may have a case if:

  • You took Ozempic, Wegovy, Mounjaro, Zepbound, Saxenda, or a similar GLP-1 drug — for weight loss or diabetes
  • You were later diagnosed with gastroparesis (stomach paralysis), had to have your gallbladder removed, or developed sudden vision loss
  • Your health problem happened after you started taking the drug

You do not need to have a lawsuit already filed. You do not need a lawyer already. The form on this page is a free first step where a real person reviews your situation and tells you if it may be a match.

⏰ Don’t Wait — Deadlines Apply to Every Case

Every state has a deadline for filing a personal injury case. In most states it’s two to four years from when you were hurt or when you found out the drug may have caused your problem. Once that deadline passes, you lose the right to recover — even if you clearly qualify. Checking if you qualify takes two minutes and is completely free.

See If You Qualify — Free
No obligation · No fee unless you win · A real person reviews every submission

What Happens If You File

Here’s the real process, in plain English:

Step 1 — You fill out the form

It takes about two minutes. You share which drug you took, what happened to you, and when. No medical records needed at this stage.

Step 2 — A real person reviews it

Someone from our intake team reads every submission. If your information looks like it may fit the case, they reach out within about a week. If you don’t hear back within seven days, please contact another law firm before your deadline passes.

Step 3 — A short conversation

If you look like a potential match, someone will reach out to go over the details — which drug, how long you took it, what happened, what treatment you needed. No pressure. No cost.

Step 4 — If you move forward, you sign a simple agreement

The agreement says you owe nothing unless your case wins or settles. If it does, the law firm takes a percentage; the rest is yours. You are not required to go to court or testify.

Common Questions

I only took Ozempic for a short time. Does that matter?

It depends on what happened to you. Some people developed serious stomach problems even after a few months of use. Submit your information and let a real person evaluate it — there’s no cost to check.

My doctor prescribed it for diabetes, not weight loss. Does that count?

Yes. The case includes people who took these drugs for diabetes management and were injured, not just those who used them for weight loss.

What if my doctor told me the stomach problem was something else?

That happens. Some GLP-1 injuries took time to connect to the drug. Gastroparesis, in particular, is sometimes diagnosed under other names first. If the timing lines up — you took the drug, then developed stomach problems — it’s worth checking.

Does it cost anything?

Nothing. The form is free. If you move forward, there are no upfront costs. You only pay if money is recovered for you.

Ready to Check If You Qualify?

If you took Ozempic, Wegovy, Mounjaro, or a similar weight loss shot and had serious stomach problems, gallbladder surgery, or vision changes — fill out the form below. A real person will review your information. If you may have a case, someone will reach out within one week.

If you don’t hear back within seven days, please reach out to another law firm. Every case has a deadline, and once it passes, you cannot recover.

For a full breakdown of the Ozempic stomach paralysis case — including what gastroparesis is and what the legal process looks like step by step — see our detailed Ozempic stomach paralysis page.

Check If You Qualify — Free & Secure
2 minutes · No fee unless you win · A real person reviews every submission

Sources

  1. U.S. District Court for the Eastern District of Pennsylvania. Case docket, In re: Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094. Docket as of April 2026.
  2. ConsumerShield. “TOP 10 Active Mass Torts By Cases (April 2026).” consumershield.com. Accessed April 29, 2026.
  3. ConsumerShield. “Current Mass Tort Cases: News and Updates (2026).” consumershield.com. Accessed April 29, 2026.
  4. Ferrer Poirot Feller. “Top Mass Tort Cases to Watch in 2026.” lawyerworks.com. Accessed April 2026.
  5. U.S. Food and Drug Administration. Approved drug labeling for semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). FDA.gov.
  6. Mass Torts Made Perfect (MTMP). Mass torts news updates, April 2026. mtmp.com.

More Consumer News

See If You Qualify